Population-based assessment of determining predictors for quality of prostate cancer surveillance

Karim Chamie, Stephen Williams, Dawn L. Hershman, Jason D. Wright, Paul L. Nguyen, Jim C. Hu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

BACKGROUND Despite recent interest in the overdiagnosis and overtreatment of prostate cancer, the acceptance of expectant management for patients with indolent prostate cancer has remained slow. Moreover, the intensity of surveillance strategies remains to be elucidated. The objective of this study was to determine the population-based intensity of surveillance strategy among patients diagnosed with localized prostate cancer who undergo watchful waiting/active surveillance and those who receive active treatment. METHODS Linked Surveillance, Epidemiology, and End Results (SEER)-Medicare data were used to identify men diagnosed with prostate cancer from 2004 to 2007 who were followed until December 31, 2009. Bivariate and multivariate regression analyses were used to quantify the use of prostate-specific antigen tests, office visits, and second prostate biopsies within 2 years of diagnosis. RESULTS Compared with patients who were receiving active treatment, those who were undergoing watchful waiting/active surveillance were less likely to receive prostate-specific antigen testing and to attend office visits within the 2 years after diagnosis (P

Original languageEnglish (US)
Pages (from-to)4150-4157
Number of pages8
JournalCancer
Volume121
Issue number23
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Watchful Waiting
Office Visits
Prostate-Specific Antigen
Population
Medicare
Prostate
Epidemiology
Multivariate Analysis
Regression Analysis
Biopsy
Therapeutics
Medical Overuse

Keywords

  • prostate cancer
  • quality
  • surveillance
  • treatments
  • use

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chamie, K., Williams, S., Hershman, D. L., Wright, J. D., Nguyen, P. L., & Hu, J. C. (2015). Population-based assessment of determining predictors for quality of prostate cancer surveillance. Cancer, 121(23), 4150-4157. https://doi.org/10.1002/cncr.29574

Population-based assessment of determining predictors for quality of prostate cancer surveillance. / Chamie, Karim; Williams, Stephen; Hershman, Dawn L.; Wright, Jason D.; Nguyen, Paul L.; Hu, Jim C.

In: Cancer, Vol. 121, No. 23, 01.12.2015, p. 4150-4157.

Research output: Contribution to journalArticle

Chamie, K, Williams, S, Hershman, DL, Wright, JD, Nguyen, PL & Hu, JC 2015, 'Population-based assessment of determining predictors for quality of prostate cancer surveillance', Cancer, vol. 121, no. 23, pp. 4150-4157. https://doi.org/10.1002/cncr.29574
Chamie, Karim ; Williams, Stephen ; Hershman, Dawn L. ; Wright, Jason D. ; Nguyen, Paul L. ; Hu, Jim C. / Population-based assessment of determining predictors for quality of prostate cancer surveillance. In: Cancer. 2015 ; Vol. 121, No. 23. pp. 4150-4157.
@article{9a06e184ed8b4cdc8f0731d2d9db0c06,
title = "Population-based assessment of determining predictors for quality of prostate cancer surveillance",
abstract = "BACKGROUND Despite recent interest in the overdiagnosis and overtreatment of prostate cancer, the acceptance of expectant management for patients with indolent prostate cancer has remained slow. Moreover, the intensity of surveillance strategies remains to be elucidated. The objective of this study was to determine the population-based intensity of surveillance strategy among patients diagnosed with localized prostate cancer who undergo watchful waiting/active surveillance and those who receive active treatment. METHODS Linked Surveillance, Epidemiology, and End Results (SEER)-Medicare data were used to identify men diagnosed with prostate cancer from 2004 to 2007 who were followed until December 31, 2009. Bivariate and multivariate regression analyses were used to quantify the use of prostate-specific antigen tests, office visits, and second prostate biopsies within 2 years of diagnosis. RESULTS Compared with patients who were receiving active treatment, those who were undergoing watchful waiting/active surveillance were less likely to receive prostate-specific antigen testing and to attend office visits within the 2 years after diagnosis (P",
keywords = "prostate cancer, quality, surveillance, treatments, use",
author = "Karim Chamie and Stephen Williams and Hershman, {Dawn L.} and Wright, {Jason D.} and Nguyen, {Paul L.} and Hu, {Jim C.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1002/cncr.29574",
language = "English (US)",
volume = "121",
pages = "4150--4157",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "23",

}

TY - JOUR

T1 - Population-based assessment of determining predictors for quality of prostate cancer surveillance

AU - Chamie, Karim

AU - Williams, Stephen

AU - Hershman, Dawn L.

AU - Wright, Jason D.

AU - Nguyen, Paul L.

AU - Hu, Jim C.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - BACKGROUND Despite recent interest in the overdiagnosis and overtreatment of prostate cancer, the acceptance of expectant management for patients with indolent prostate cancer has remained slow. Moreover, the intensity of surveillance strategies remains to be elucidated. The objective of this study was to determine the population-based intensity of surveillance strategy among patients diagnosed with localized prostate cancer who undergo watchful waiting/active surveillance and those who receive active treatment. METHODS Linked Surveillance, Epidemiology, and End Results (SEER)-Medicare data were used to identify men diagnosed with prostate cancer from 2004 to 2007 who were followed until December 31, 2009. Bivariate and multivariate regression analyses were used to quantify the use of prostate-specific antigen tests, office visits, and second prostate biopsies within 2 years of diagnosis. RESULTS Compared with patients who were receiving active treatment, those who were undergoing watchful waiting/active surveillance were less likely to receive prostate-specific antigen testing and to attend office visits within the 2 years after diagnosis (P

AB - BACKGROUND Despite recent interest in the overdiagnosis and overtreatment of prostate cancer, the acceptance of expectant management for patients with indolent prostate cancer has remained slow. Moreover, the intensity of surveillance strategies remains to be elucidated. The objective of this study was to determine the population-based intensity of surveillance strategy among patients diagnosed with localized prostate cancer who undergo watchful waiting/active surveillance and those who receive active treatment. METHODS Linked Surveillance, Epidemiology, and End Results (SEER)-Medicare data were used to identify men diagnosed with prostate cancer from 2004 to 2007 who were followed until December 31, 2009. Bivariate and multivariate regression analyses were used to quantify the use of prostate-specific antigen tests, office visits, and second prostate biopsies within 2 years of diagnosis. RESULTS Compared with patients who were receiving active treatment, those who were undergoing watchful waiting/active surveillance were less likely to receive prostate-specific antigen testing and to attend office visits within the 2 years after diagnosis (P

KW - prostate cancer

KW - quality

KW - surveillance

KW - treatments

KW - use

UR - http://www.scopus.com/inward/record.url?scp=84948571227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948571227&partnerID=8YFLogxK

U2 - 10.1002/cncr.29574

DO - 10.1002/cncr.29574

M3 - Article

VL - 121

SP - 4150

EP - 4157

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 23

ER -